花青素寡聚物(葡萄皮肤提取物)给药改善了干眼症:一种随机的,双盲的,安慰剂对照的研究。
摘要来源:
Clin Exp Ophthalmol。 2023年3月; 51(2):122-130。 EPUB 2023 2月3日。PMID: 36703096 Yujiao Tang,Hyun Pil Yang,Eun-Kyung Kim
文章隶属关系:meiqi fan
摘要:
方法: 这项研究研究了花青素低聚物(葡萄皮肤提取物)的临床功效,以治疗干眼。一百八名干眼症患者是随机的y分为安慰剂和治疗组,每个组为54例。安慰剂组接受了麦芽糊精(800 mg/day),治疗组接受了花青素低聚物(800 mg/day)。 Clinical efficacy, clinical indices, and occurrence of adverse reactions were compared between the two groups.
RESULTS: Anthocyanin oligomers were safe and effective in mild-to-moderate dry eye disease, improving the tear break-up time, intraocular pressure, ocular surface disease, and patient症状学。
结论: 在干眼症患者治疗时使用口服花青素寡聚物可以增强治疗效果并提高患者的治疗质量,同时确保治疗的安全性,使其适用于